BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Garrido I, Lopes S, Macedo G. Hit the Road JAK! The Role of New Oral Treatment in Inflammatory Bowel Disease. Inflamm Bowel Dis 2021;27:2010-22. [PMID: 33742651 DOI: 10.1093/ibd/izab037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Herrera-deGuise C, Serra-Ruiz X, Lastiri E, Borruel N. JAK inhibitors: A new dawn for oral therapies in inflammatory bowel diseases. Front Med (Lausanne) 2023;10:1089099. [PMID: 36936239 DOI: 10.3389/fmed.2023.1089099] [Reference Citation Analysis]
2 Syabbalo N. The role of interleukin-6 and janus kinases in the pathogenesis, and treatment of SARS-CoV-2. JLPRR 2022;9:17-32. [DOI: 10.15406/jlprr.2022.09.00273] [Reference Citation Analysis]
3 Kim JW, Kim SY. The Era of Janus Kinase Inhibitors for Inflammatory Bowel Disease Treatment. Int J Mol Sci 2021;22:11322. [PMID: 34768752 DOI: 10.3390/ijms222111322] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]